Canine genetics offers new mechanisms for the study of human cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 11, 2007, Pages 2181-2183

  Cadieu, Edouard ^a   Ostrander, Elaine A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MODEL; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; DOG; EDITORIAL; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HORMONE ACTION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; KIDNEY CANCER; LINKAGE ANALYSIS; MAMMALIAN GENETICS; MENSTRUAL CYCLE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA;

ANIMALS; CARCINOMA IN SITU; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; FEMALE; HUMANS; MALE; NEOPLASMS;

EID: 38849146944     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2667     Document Type: Editorial

References (43)

1. Antuofermo E, Miller MA, Pirino S, Xie J, Badve S, Mohammed S. Spontaneous mammary intraepithelial lesions in dogs - a model of breast cancer. Cancer Epidemiol Biomarkers Prev 2007:16:2247-56.
2. Silverstein MJ. Ductal carcinoma in situ of the breast. Ann Rev Med 2000;51:17-32.
3. Page DL, Dupont WD. Anatomic markers of human premalignancy and risk of breast cancer. Cancer 1990;15:1326-35.
4. Skinner KA, Silverstein MJ. The management of ductal carcinoma in situ of the breast. Endocr Relat Cancer 2001;8:33-45.
5. Shoker BS, Jarvis C, Clarke RB, et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol 1999;155:1811-5.
6. Yang WY, Liu CH, Chang CJ, Lee CC, Chang KJ, Lin CT. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours. J Comp Pathol 2006;134:70-9.
7. Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, Gerber B. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma in situ (DCIS) versus invasive breast cancer alone. Anticancer Res 2005;25:1719-23.
8. American Veterinary Medical Association U.S. Pet Ownership and Demographics Sourcebook. Schaumburg, ILL: American Veterinary Medical Association; 2002.
9. Sutter NB, Ostrander EA. Dog star rising: the canine genetic system. Nat Rev Genet 2004;5:900-10.
10. Glickman LT, Raghavan M, Knapp DW, Bonney PL, Dawson MH. Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish terriers. J Am Vet Med Assoc 2004;224:1290-7.
11. Storb R, Thomas ED. Graft-versus-host disease in dog and man: the Seattle experience. In: Möller G, editor. Immunological reviews, no. 88. Copenhagen: Munksgaard; 1985. p. 215-38.
12. Vail DM, MacEwen EG. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Investigation 2000;18:781-92.
13. Bronson RT. Variation in age at death of dogs of different sexes and breeds. Am J Vet Res 1982;43:2057-9.
14. Dorn CR. Epidemiology of canine and feline tumors. Comp Cont Educ Pract Vet 1976;12:307-12.
15. Ostrander EA, Kruglyak L. Unleashing the canine genome. Genome Res 2000;10:1271-4.
16. Ostrander EA, Wayne RK. The canine genome. Genome Res 2005;15:1706-16.
17. Knapp D, Glickman N, DeNicola D, Bonney P, Lin T, Glickman L. Naturally occurring canine transitional cell carcinoma of the urinary bladder: a relevant model of human invasive bladder cancer. Urol Oncol 2000;5:47-59.
18. Leifer CE, Matus RE. Canine lymphoma: clinical considerations. Semin Vet Med Surg Small Anim 1986;1:43-50.
19. Valli VE, Vernau W, de Lorimier LP, Graham PS, Moore PF. Canine indolent nodular lymphoma. Vet Pathol 2006;43:241-56.
20. Mueller F, Fuchs B, Kaser-Hotz B. Comparative biology of human and canine osteosarcoma. Anticancer Res 2007;27:155-64.
21. Bergman PJ. Canine oral melanoma. Clin Tech Small Anim Pract 2007;22:55-60.
22. MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 1990;9:125-36.
23. Moore PF, Rosin A. Malignant histiocytosis of Bernese mountain dogs. Vet Pathol 1986;23:1-10.
24. Affolter VK, Moore PF. Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. Am J Dermatopathol 2000;22:40-8.
25. Onions DE. A prospective survey of familial canine lymphosarcoma. J Natl Cancer Inst 1984;72:909-12.
26. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
27. Teske E, Naan EC, van Dijk EM, Van Garderen E, Schalken JA. Canine prostate carcinoma: epidemiological evidence of an increased risk in castrated dogs. Mol Cell Endocrinol 2002;197:251-5.
28. Waters DJ, Hayden DW, Bell FW, Klausner JS, Qian J, Bostwick DG. Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer. Prostate 1997;30:92-7.
29. Navone NM, Logothetis CJ, von Eschenbach AC, Troncoso P. Model systems of prostate cancer: uses and limitations. Cancer Metastasis Rev 1998;17:361-71.
30. Weaver AD. Fifteen cases of prostatic carcinoma in the dog. Vet Rec 1981;109:71-5.
31. Bryan JN, Keeler MR, Henry CJ, Bryan ME, Hahn AW, Caldwell CW. A population study of neutering status as a risk factor for canine prostate cancer. Prostate 2007;67:1174-81.
32. Wu CP, Gu FL. The prostate in eunuchs. Prog Clin Biol Res 1991;370:249-55.
33. Lytton B. Prostate cancer: a brief history and the discovery of hormonal ablation treatment. J Urol 2001;165:1859-62.
34. Dobson JM, Samuel S, Milstein H, Rogers K, Wood JL. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J Small Anim Pract 2002;43:240-6.
35. Schneider R. Comparison of age, sex, and incidence rates in human and canine breast cancer. Cancer 1970;26:419-26.
36. Egenvall A, Bonnett BN, Ohagen P, Olson P, Hedhammar A, von Euler H. Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med 2005;69:109-27.
37. Parker H, Kukekova A, Akey D, et al. Breed relationships facilitate fine mapping studies: a 7.8 kb deletion cosegregates with collie eye anomaly across multiple dog breeds. Genome Research. In press 2007.
38. Parker HG, Kim LV, Sutter NB, et al. Genetic structure of the purebred domestic dog. Science 2004;304:1160-4.
39. Knapp DW. Animal models: naturally occurring canine urinary bladder cancer. In: Lerner SP, Schoenberg MP, Sternberg CN, editors. Textbook of bladder cancer. Oxon (United Kingdom): Taylor and Francis; 2006. p. 171-5.
40. Goldstein O, Zangerl B, Pearce-Kelling S, et al. Linkage disequilibrium mapping in domestic dog breeds narrows the progressive rod-cone degeneration interval and identifies ancestral disease-transmitting chromosome. Genomics 2006;88:541-50.
41. Jonasdottir TJ, Mellersh CS, Moe L, et al. Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs. Proc Natl Acad Sci U S A 2000;97:4132-7.
42. Lingaas F, Comstock KE, Kirkness EF, et al. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Hum Mol Genet 2003;12:3043-53.
43. Waters DJ. High-grade prostatic intraepithelial neoplasia in dogs. Eur Urol 1999;35:456-8.